| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Nov 12, 2025 | HAEMONETICS CORP | Director | Buy | 90.0 | +1,400 | 5.99% | ✗ | $98.8K |
| Mar 7, 2023 | Mar 8, 2023 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -3,549 | -25.92% | ✗ | $783.4K |
| Aug 15, 2022 | Aug 16, 2022 | HAEMONETICS CORP | Director | Sell | 20.0 | -8,016 | -33.06% | ✗ | $590.9K |
| Jun 8, 2022 | Jun 9, 2022 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -3,159 | -18.75% | ✗ | $324.8K |
| May 26, 2021 | May 28, 2021 | HAEMONETICS CORP | Director | Sell | 20.0 | -11,813 | -39.05% | ✗ | $650.9K |
| May 12, 2021 | May 14, 2021 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -4,204 | -23.88% | ✗ | $525.3K |
| Nov 16, 2020 | Nov 17, 2020 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -2,993 | -13.86% | ✗ | $360.5K |
| Dec 31, 2019 | Apr 13, 2020 | HAEMONETICS CORP | Director | Sell | 15.0 | -11,772 | -15.55% | ✓ | $1.1M |
| Nov 13, 2019 | Nov 14, 2019 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -4,168 | -17.62% | ✗ | $268K |
| Aug 14, 2018 | Nov 9, 2018 | HAEMONETICS CORP | Director | Sell | 20.0 | -11,907 | -13.03% | ✓ | $1.2M |
| Aug 20, 2018 | Aug 20, 2018 | AXON ENTERPRISE, INC. | Director | Sell | 20.0 | -7,097 | -22.75% | ✗ | $456.6K |
| Jun 7, 2013 | Jun 29, 2018 | AXON ENTERPRISE, INC. | Director | Sell | 22.5 | -5,170 | -5.65% | ✗ | $70.8K |
| Jan 2, 2018 | Jan 3, 2018 | HAEMONETICS CORP | Director | Sell | 12.5 | -7,118 | -21.01% | ✓ | $448.4K |
| May 15, 2017 | May 17, 2017 | HAEMONETICS CORP | Director | Sell | 20.0 | -8,580 | -27.66% | ✗ | $356K |
| Feb 27, 2015 | Mar 3, 2015 | HAEMONETICS CORP | Director | Sell | 20.0 | -11,328 | -47.75% | ✗ | $507.5K |
| Nov 19, 2012 | Nov 21, 2012 | HAEMONETICS CORP | Director | Sell | 20.0 | -4,592 | -52.37% | ✗ | $368K |
| Nov 16, 2012 | Nov 20, 2012 | HAEMONETICS CORP | Director | Sell | 20.0 | -6,000 | -58.96% | ✗ | $478K |